Pharmacology & ToxicologybioRxivPreprint
Discovery and characterization of highly potent and selective covalent inhibitors of SARS-CoV-2 PLpro
Jian Wu, Tasneem M. Vaid, Ho Shin Kim…·Min Li
This study identifies and characterizes two covalent PLpro inhibitors, HUP0109 and DX-027, as potential treatments for SARS-CoV-2.
3 citations